Physician profile
Wallace Curry
NPI 1407892482
$1,389.54
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $848 · 2022: $169 · 2023: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $835.38 | 2020 | |
| Cook Medical LLC | $145.81 | 2019 | |
| Medtronic, INC. | $78.47 | 2022 | |
| Astellas Pharma US INC | $53.45 | 2023 | Myrbetriq |
| Procept Biorobotics Corporation | $47.19 | 2023 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $35.64 | 2019-2022 | |
| Boston Scientific Corporation | $31.84 | 2019 | |
| Abbvie INC. | $31.35 | 2023 | Lupron Depot |
| Urovant Sciences INC | $27.18 | 2022 | |
| Axonics, INC. | $18.55 | 2022 | |
| Progenics Pharmaceuticals, INC. | $18.15 | 2023 | Pylarify |
| Sumitomo Pharma America, INC. | $17.93 | 2023 | Orgovyx |
| 180 Medical, INC. | $13.04 | 2020 | |
| Merck Sharp & Dohme LLC | $12.08 | 2022 | |
| Pfizer INC. | $12.03 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Curry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.